Dr. Feng  Niu

Dr. Feng Niu

Consultant
Jilin University, China


Highest Degree
Ph.D. in Medicine from Jilin University, China

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Cancer Biochemistry
62%
Molecular Biology
90%
Osteoporosis
75%
Oncology
55%

Selected Publications

  1. Zhao, S., C.Y. Xu, A. Zhu, L. Ye and L. Lv et al., 2017. Comparison of the efficacy and safety of 3 treatments for patients with osteoporotic vertebral compression fractures: A network meta-analysis. Med., 10.1097/MD.0000000000007328.
    CrossRef  |  Direct Link  |  

  2. Zhao, S., F. Niu, C.Y. Xu, Y. Liu and L. Ye et al., 2016. Diosgenin prevents bone loss on retinoic acid-induced osteoporosis in rats. Irish J. Med. Sci., 185: 581-587.
    Direct Link  |  

  3. Zhao, S., F. Niu, C.Y. Xu, L. Ye and G.B. Bi et al., 2015. Microarray and ChIP-seq data analysis revealed changes in p53-mediated transcriptional regulation in Nutlin-3-treated U2OS cells. Mol. Med. Rep., 15: 4284-4290.
    CrossRef  |  Direct Link  |  

  4. Niu, F., S. Zhao, C.Y. Xu, H. Sha and G.B. Bi et al., 2015. Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2. Oncol. Lett., 10: 2415-2421.
    CrossRef  |  Direct Link  |  

  5. Niu, F., S. Zhao, C.Y. Xu, L. Chen and L. Ye et al., 2014. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma. Asian Pac. J. Cancer Prev., 15: 10797-10801.
    Direct Link  |